Hiccups are not listed as a side effect in the official Summary of Product Characteristics (SmPC) for Saxenda as approved by the Medicines and Healthcare products Regulatory Agency (MHRA)
Once these pouches form they remain for life but frequently cause no problems
Research protocols typically use daily dosing for 714 days during the induction phase, with therapeutic effects lasting 30+ days post-treatment despite complete plasma clearance within 12 hours of the final dose
This stage often builds momentum, but staying consistent and following proper dosage is key
Compelling pieces of evidence have shown that n-3 intake, including maternal n-3 consumption, has beneficial effects in alcohol-elicited neurodegeneration, particularly in FASD, and alcoholic liver damage, also improving alcoholic gastric hemorrhage (67), pancreatitis (68) and angiogenesis (55) (Supplementary Table 1)